Dialysis world news


Gene Mutated In 1 In 5 Patients With Common Form Of Renal Cancer - Medical News Today (press release)
Medical News Today (press release)
The gene - called PBRM1 - was found to be mutated in 88 cases out of 257 clear cell renal cell carcinomas (ccRCC) analysed, making it the most prevalent to

...

 
A retrospective study comparing the clinical efficacy of laparoscopic ... - UroToday
UroToday
To compare the clinical outcomes of laparoscopic cryoablation (LCA) and laparoscopic partial nephrectomy (LPN) in the treatment of renal cell carcinoma

...

 
FMC sells $900 mln in bonds to fund latest takeover - Reuters
Reuters
The world's largest dialysis company said it would issue $500 million of senior unsecured notes due 2021 and 300 million euros ($403 million) of senior ...
Hidden Cleveland: Fresenius providing critical health care Cleveland Daily Banner
Fresenius Medical Intends To Sell US$500 Mln And €300 Million Of Senior Notes RTT News
Fresenius Medical Care Announces the Offering of US$500 Million and EUR300

...

 
Fresenius recalls some Combiset blood tubing sets because of kinking risk.
FDA: RECALLING FIRM/MANUFACTURER Recalling Firm: Fresenius Medical Care Holdings, Inc., Waltham, MA, by letter dated November 19, 2010. Manufacturer: Fresenius Medical Care, Reynosa, Tamulipas, Mexico. Firm initiated recall is ongoing. REASON Hemodialysis Blood tubing Sets may develop kinking of the arterial line

...

 
Inhaled insulin fails to get FDA approval; 2 additional studies were requested.
Bloomberg: MannKind Corp., the biotechnology company founded by billionaire inventor Alfred Mann, failed to win approval from U.S. regulators to market its first product, an inhaled insulin called Afrezza, for diabetes.

...

 
<< Start < Prev 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 Next > End >>

Page 1114 of 2630
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.